Your session is about to expire
← Back to Search
Ravulizumab for Myasthenia Gravis
Study Summary
This trial will test if ravulizumab is safe and effective for treating generalized myasthenia gravis.
- Myasthenia Gravis
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 3 trial • 195 Patients • NCT03056040Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
When did the FDA give ravulizumab their official seal of approval?
"There is existing evidence that Ravulizumab is safe as well as effective, so it received a score of 3."
Are researchers looking for more participants at this moment?
"The clinical trial in question is not seeking patients at the moment, as evidenced by an inactive status on clinicaltrials.gov. This particular study was created on March 26th, 2019 and updated for the last time on May 3rd, 2022. There are a total of 103 other trials that are currently looking for participants."
Does this medical research have any precedents?
"As of now, there are 16 ongoing studies for Ravulizumab in 31 countries and 193 cities. The first clinical trial for the drug was sponsored by Alexion Pharmaceuticals in 2016 and completed its Phase 3 approval stage that same year. Since then, 18283 more trials have been conducted."
What conditions does Ravulizumab help ameliorate?
"Ravulizumab is frequently used to manage disease activity, but it can also help patients with hemolysis, thrombotic microangiopathies, and atypical hemolytic uremic syndrome."
What other similar medical experiments have there been with Ravulizumab?
"Currently, there are 16 active clinical trials for Ravulizumab with 13 being in Phase 3. Most of these studies taking place in Whittier, California; however, 842 locations across the globe are conducting similar research."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger